Hapten-protein conjugates and the use therof

Details Hapten-protein conjugates and the use therof Hapten-protein conjugates and the use therof

1989-01-25

1991-07-16

Russel, Jeffrey E.

Chemistry: molecular biology and microbiology

Carrier-bound or immobilized enzyme or microbial cell;...

Enzyme or microbial cell is immobilized on or in an organic...

435174, 435188, 435192, 435207, 530363, 530387, 530405, 530406, 530395, C07K 1712, C12N 1112, C12Q 128

Patent

active

050325183

ABSTRACT:
The present invention provides a hapten-protein conjugate, wherein a hapten is bound to the reducing end of a sugar which consists of up to 10 monosaccharide units and on a free CH.sub.2 OH group on the other end of the sugar, which is in the .alpha.-position to a hydroxyl group, is bound a protein.

REFERENCES:
patent: 4194048 (1980-03-01), Buckler
patent: 4218539 (1980-08-01), Weltman
patent: 4277460 (1981-07-01), Kojima et al.
patent: 4378428 (1983-03-01), Fatina et al.
patent: 4550019 (1985-10-01), Polson
patent: 4740476 (1988-08-01), Kubodera et al.
Blair et al. (1983) J. Immunol. Methods 59:129-143.
Erlanger et al. (1959) J. Biol. Chem. 234:1090-1094.
Monsigny et al. (1980) FEBS Lett. 119(1):181-185.

Affiliated with

Also associated with

Rating

Hapten-protein conjugates and the use therof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hapten-protein conjugates and the use therof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hapten-protein conjugates and the use therof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-131270